Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-036277
Filing Date
2024-11-26
Accepted
2024-11-26 16:46:57
Documents
69
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q wint20240930c_10q.htm   iXBRL 10-Q 1642923
2 EXHIBIT 31.1 ex_722473.htm EX-31.1 15832
3 EXHIBIT 31.2 ex_749551.htm EX-31.2 13060
4 EXHIBIT 32.1 ex_722474.htm EX-32.1 8899
  Complete submission text file 0001437749-24-036277.txt   7982694

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA wint-20240930.xsd EX-101.SCH 73257
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wint-20240930_cal.xml EX-101.CAL 39123
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wint-20240930_def.xml EX-101.DEF 574427
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE wint-20240930_lab.xml EX-101.LAB 431809
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wint-20240930_pre.xml EX-101.PRE 591111
72 EXTRACTED XBRL INSTANCE DOCUMENT wint20240930c_10q_htm.xml XML 1011461
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

EIN.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39290 | Film No.: 241504740
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)